NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells

• Rebecca Kan ,

  Contributed equally to this work with: Rebecca Kan, Wai Ho Shuen

  Affiliation Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯
• Wai Ho Shuen ,

  Contributed equally to this work with: Rebecca Kan, Wai Ho Shuen

  Current address: Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore

  Affiliation Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯
• Hong Lok Lung,

  Affiliations Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Center for Cancer Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯
• Arthur Kwok Leung Cheung,

  Affiliations Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Center for Cancer Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯
• Wei Dai,

  Affiliation Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯
• Dora Lai-Wan Kwong,

  Affiliations Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Center for Cancer Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯
• Wai Tong Ng,

  Affiliations Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong (SAR), PR China

  ⨯
• Anne Wing Mui Lee,

  Affiliations Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Department of Clinical Oncology, The University of Hong Kong—Shen Zhen Hospital, PR China

  ⨯
• Chun Chung Yau,

  Affiliations Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Department of Oncology, Princess Margaret Hospital, Hong Kong (SAR), PR China

  ⨯
• Roger Kai Cheong Ngan,

  Affiliations Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong (SAR), PR China

  ⨯
• Stewart Yuk Tung,

  Affiliations Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong (SAR), PR China

  ⨯
• Maria Li Lung

  * E-mail: mlilung@hku.hk

  Affiliations Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Center for Cancer Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China, Center for Nasopharyngeal Carcinoma Research, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong (SAR), PR China

  ⨯